Tech Company Financing Transactions

64x Bio Funding Round

Lifeforce Ventures, Alix Ventures and BoxGroup invested in a $55 million Series A funding round for 64x Bio. This venture round was announced on 1/29/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

409 Illinois St.
San Francisco, CA 94158
USA

Phone

Undisclosed

Website

www.64xbio.com

Email Address

[email protected]

Overview

64x Bio is building a platform that radically increases the speed and scale of mammalian cell line discovery. 64x Bio is transforming the future of cell and gene therapy manufacturing with high throughput discovery and design of enhanced cell lines for next-generation biomanufacturing and therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Alexis Rovner

        

Co-Founder

George Church

        

Co-Founder

Pam Silver

        

Co-Founder

David Thompson

        

Co-Founder

Jeffery Way

        

VP - General Counsel

Gregory Sieczkiewicz

        

Browse more venture capital transactions:

Prev: 1/29/2022: Polar Security venture capital transaction
Next: 1/29/2022: Zingtree venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary